Skip to main content
Signal8

Flowers Cynthia Louise

SEC insider (Form 3/4/5 filer). CIK 0001741455. Director at LISATA THERAPEUTICS, INC. (LSTA) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 9, 2026. Located in BASKING RIDGE, NJ.

Companies Flowers Cynthia Louise has filed insider reports for

  • LISATA THERAPEUTICS, INC. (LSTA): Director
  • G1 Therapeutics, Inc. (GTHX): Director
Flowers Cynthia Louise profile photo

Flowers Cynthia Louise

CIK: 0001741455

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LISATA THERAPEUTICS, INC. logo
LSTA

LISATA THERAPEUTICS, INC.

Director
G1 Therapeutics, Inc. logo
GTHX

G1 Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • LISATA THERAPEUTICS, INC. logo
    LSTA

    LISATA THERAPEUTICS, INC.

    Jan 9, 2026
    Award
    Direct
    30.5K shares-
  • LISATA THERAPEUTICS, INC. logo
    LSTA

    LISATA THERAPEUTICS, INC.

    Jan 9, 2025
    Award
    Direct
    15.8K shares-
  • G1 Therapeutics, Inc. logo
    GTHX

    G1 Therapeutics, Inc.

    Sep 18, 2024
    Disposition
    Direct
    20K shares-
  • G1 Therapeutics, Inc. logo
    GTHX

    G1 Therapeutics, Inc.

    Sep 18, 2024
    Tender Offer
    Direct
    15.9K shares-

1-4 of 4